Session

PP 05 IBD (Posters)

TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB AND VEDOLIZUMAB: ADHERENCE, SATISFACTION AND SAFETY PROFILE IN A COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB AND VEDOLIZUMAB: ADHERENCE, SATISFACTION AND SAFETY PROFILE IN A COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

AUTOPHAGY/OXIDATIVE STRESS IMBALANCE IN STENOSING CROHN’S DISEASE PATIENTS: A PROOF-OF-CONCEPT STUDY
AUTOPHAGY/OXIDATIVE STRESS IMBALANCE IN STENOSING CROHN’S DISEASE PATIENTS: A PROOF-OF-CONCEPT STUDY

BEING YOUNG AND WOMEN ARE RISK FACTORS FOR MALNUTRITION ACCORDING TO GLIM CRITERIA IN INFLAMMATORY BOWEL DISEASE OUTPATIENS
BEING YOUNG AND WOMEN ARE RISK FACTORS FOR MALNUTRITION ACCORDING TO GLIM CRITERIA IN INFLAMMATORY BOWEL DISEASE OUTPATIENS

IBD PATIENTS SHOW SIGNS OF RELEVANT DISEASE ACTIVITY – RESULTS FROM THE PORTUGUESE COHORT OF THE IBD PODCAST STUDY
IBD PATIENTS SHOW SIGNS OF RELEVANT DISEASE ACTIVITY – RESULTS FROM THE PORTUGUESE COHORT OF THE IBD PODCAST STUDY

ACCURACY OF PANMAYO ENDOSCOPIC SCORE IN PREDICTING LONG-TERM DISEASE OUTCOMES IN ULCERATIVE COLITIS– A PROMISING SCORING SYSTEM
ACCURACY OF PANMAYO ENDOSCOPIC SCORE IN PREDICTING LONG-TERM DISEASE OUTCOMES IN ULCERATIVE COLITIS– A PROMISING SCORING SYSTEM

ANTI-INFLAMMATORY EFFECT OF LMT503, A MODULATOR OF CELL METABOLISM, AMELIORATES MURINE ADOPTIVE T CELL TRANSFER-INDUCED COLITIS
ANTI-INFLAMMATORY EFFECT OF LMT503, A MODULATOR OF CELL METABOLISM, AMELIORATES MURINE ADOPTIVE T CELL TRANSFER-INDUCED COLITIS

A HIGHER TH2/TREG RATIO MAY BE A MARKER OF REFRACTORY ULCERATIVE COLITIS WITH LONGER DISEASE DURATION AND FREQUENT USE OF STEROIDS AND/OR IMMUNOSUPPRESSANTS, WHEREAS HLA GENOTYPE IS NOT
A HIGHER TH2/TREG RATIO MAY BE A MARKER OF REFRACTORY ULCERATIVE COLITIS WITH LONGER DISEASE DURATION AND FREQUENT USE OF STEROIDS AND/OR IMMUNOSUPPRESSANTS, WHEREAS HLA GENOTYPE IS NOT

PRELIMINARY DATA ON THE EFFICACY OF USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS IN A 'REAL-WORLD' CLINICAL SETTING
PRELIMINARY DATA ON THE EFFICACY OF USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS IN A 'REAL-WORLD' CLINICAL SETTING

SUBCUTANEOUS INFLIXIMAB – A REAL WORLD EXPERIENCE
SUBCUTANEOUS INFLIXIMAB – A REAL WORLD EXPERIENCE

TWELVE-MONTH OUTCOMES OF TREATMENT WITH USTEKINUMAB IN PATIENTS WITH CROHN’S DISEASE, IN A REAL-LIFE SETTING IN GREECE: INTERIM ANALYSIS OF THE ‘REASSURE’ STUDY
TWELVE-MONTH OUTCOMES OF TREATMENT WITH USTEKINUMAB IN PATIENTS WITH CROHN’S DISEASE, IN A REAL-LIFE SETTING IN GREECE: INTERIM ANALYSIS OF THE ‘REASSURE’ STUDY

INFLAMMATORY BOWEL DISEASE IMPACT ON PATIENT’S SEXUAL DESIRE
INFLAMMATORY BOWEL DISEASE IMPACT ON PATIENT’S SEXUAL DESIRE

DIAGNOSIS METHODS FOR INFLAMMATORY BOWEL DISEASES USING THE FECAL, HEMATOLOGICAL, SEROLOGICAL INDICATORS, FATTY ACIDS' LEVELS OF ERYTHROCYTE MEMBRANES, AND BLOOD SERUM
DIAGNOSIS METHODS FOR INFLAMMATORY BOWEL DISEASES USING THE FECAL, HEMATOLOGICAL, SEROLOGICAL INDICATORS, FATTY ACIDS' LEVELS OF ERYTHROCYTE MEMBRANES, AND BLOOD SERUM

INCREASED PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN LEAN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE
INCREASED PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN LEAN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE

ROLE OF INTESTINAL ULTRASOUND IN THE DIAGNOSIS OF POST-OPERATIVE RECURRENCE IN CROHN’S DISEASE
ROLE OF INTESTINAL ULTRASOUND IN THE DIAGNOSIS OF POST-OPERATIVE RECURRENCE IN CROHN’S DISEASE

DFL23806, A SELECTIVE AGONIST OF GPR120, DISPLAYS UNIQUE PHARMACOLOGICAL POTENTIAL AND INHIBITS ACUTE AND CHRONIC COLITIS IN MURINE MODELS
DFL23806, A SELECTIVE AGONIST OF GPR120, DISPLAYS UNIQUE PHARMACOLOGICAL POTENTIAL AND INHIBITS ACUTE AND CHRONIC COLITIS IN MURINE MODELS

THE UROTENSIN-II RECEPTOR: A NEW PREDICTIVE MARKER OF STAGING OF ULCERATIVE COLITIS AND THERAPEUTIC RESPONSE TO INTRAVENOUS STEROID ADMINISTRATION
THE UROTENSIN-II RECEPTOR: A NEW PREDICTIVE MARKER OF STAGING OF ULCERATIVE COLITIS AND THERAPEUTIC RESPONSE TO INTRAVENOUS STEROID ADMINISTRATION

CLINICAL FEATURES AND PROGNOSIS OF SPORADIC NEOPLASIAS DETECTED IN ULCERATIVE COLITIS PATIENTS
CLINICAL FEATURES AND PROGNOSIS OF SPORADIC NEOPLASIAS DETECTED IN ULCERATIVE COLITIS PATIENTS

CLINICAL CHARACTERISTICS AND OUTCOMES OF APPENDICEAL NEOPLASMS IN INFLAMMATORY BOWEL DISEASE: A TERTIARY CARE CENTER EXPERIENCE
CLINICAL CHARACTERISTICS AND OUTCOMES OF APPENDICEAL NEOPLASMS IN INFLAMMATORY BOWEL DISEASE: A TERTIARY CARE CENTER EXPERIENCE

EXPERT CONSENSUS TO STANDARDISE TRANSCRIPTOME ANALYSIS IN INFLAMMATORY BOWEL DISEASE CLINICAL TRIALS
EXPERT CONSENSUS TO STANDARDISE TRANSCRIPTOME ANALYSIS IN INFLAMMATORY BOWEL DISEASE CLINICAL TRIALS

ASSOCIATION BETWEEN EFFICACY AND LONG-TERM OUTCOMES: FOUR YEAR RESULTS FROM THE UNIFI STUDY OF USTEKINUMAB IN ULCERATIVE COLITIS
ASSOCIATION BETWEEN EFFICACY AND LONG-TERM OUTCOMES: FOUR YEAR RESULTS FROM THE UNIFI STUDY OF USTEKINUMAB IN ULCERATIVE COLITIS

Item 701 - 720 / 826
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35
36
37 38 39 40 41 42